- Home
- OVBC vs TLSI Comparison
OVBC vs TLSI Comparison
Compare OVBC & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVBC
- TLSI
- Stock Information
- Founded
- OVBC 1872
- TLSI 2010
- Country
- OVBC United States
- TLSI United States
- Employees
- OVBC N/A
- TLSI N/A
- Industry
- OVBC Major Banks
- TLSI Medical Specialities
- Sector
- OVBC Finance
- TLSI Health Care
- Exchange
- OVBC Nasdaq
- TLSI Nasdaq
- Market Cap
- OVBC 114.0M
- TLSI 130.4M
- IPO Year
- OVBC N/A
- TLSI N/A
- Fundamental
- Price
- OVBC $23.93
- TLSI $4.25
- Analyst Decision
- OVBC
- TLSI Strong Buy
- Analyst Count
- OVBC 0
- TLSI 3
- Target Price
- OVBC N/A
- TLSI $12.67
- AVG Volume (30 Days)
- OVBC 3.0K
- TLSI 36.5K
- Earning Date
- OVBC 10-24-2024
- TLSI 11-12-2024
- Dividend Yield
- OVBC 3.68%
- TLSI N/A
- EPS Growth
- OVBC N/A
- TLSI N/A
- EPS
- OVBC 2.36
- TLSI N/A
- Revenue
- OVBC $55,881,000.00
- TLSI $24,736,000.00
- Revenue This Year
- OVBC N/A
- TLSI $62.12
- Revenue Next Year
- OVBC N/A
- TLSI $48.04
- P/E Ratio
- OVBC $9.89
- TLSI N/A
- Revenue Growth
- OVBC N/A
- TLSI 67.75
- 52 Week Low
- OVBC $19.35
- TLSI $3.32
- 52 Week High
- OVBC $25.50
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- OVBC 51.74
- TLSI 41.79
- Support Level
- OVBC $22.98
- TLSI $4.16
- Resistance Level
- OVBC $23.80
- TLSI $4.59
- Average True Range (ATR)
- OVBC 0.56
- TLSI 0.33
- MACD
- OVBC -0.05
- TLSI 0.04
- Stochastic Oscillator
- OVBC 71.49
- TLSI 22.82
About OVBC Ohio Valley Banc Corp.
Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services. The bank segmented its operating activities into two reportable segments, Banking and Consumer Finance. The majority of its total revenue is derived from the Banking segment.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.